CRINETICS PHARMACEUTICALS INC. - COMMON STOCK

Crinetics Pharmaceuticals Announces February 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10 فبراير 2025 16:44:27 بحسب Nasdaq GlobeNewswire

Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025

06 فبراير 2025 16:35:20 بحسب Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Announces January 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10 يناير 2025 17:15:15 بحسب Nasdaq GlobeNewswire

Crinetics Announces Positive Topline Results From Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia (CAH)

10 يناير 2025 07:00:00 بحسب Nasdaq GlobeNewswire

Crinetics Pharmaceuticals to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

06 يناير 2025 08:00:00 بحسب Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Appoints Isabel Kalofonos as Chief Commercial Officer

16 ديسمبر 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Announces December 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10 ديسمبر 2024 20:44:38 بحسب Nasdaq GlobeNewswire

Crinetics Announces FDA Acceptance of New Drug Application for Paltusotine for Adult Patients with Acromegaly

09 ديسمبر 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Crinetics Pharmaceuticals to Participate in Three Upcoming December Investor Conferences

15 نوفمبر 2024 09:00:00 بحسب Nasdaq GlobeNewswire

UPDATE: Crinetics Pharmaceuticals to Showcase Pipeline Advancements with Neuroendocrine Tumor Candidates at The North American Neuroendocrine Tumor Society (NANETS) Annual Meeting

14 نوفمبر 2024 16:05:00 بحسب Nasdaq GlobeNewswire

Crinetics Pharmaceuticals to Showcase Pipeline Advancements with Neuroendocrine Tumor Candidates at The North American Neuroendocrine Tumor Society (NANETS) Annual Meeting

12 نوفمبر 2024 16:07:00 بحسب Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update

12 نوفمبر 2024 16:05:00 بحسب Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Announces November 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

11 نوفمبر 2024 16:05:00 بحسب Nasdaq GlobeNewswire

Crinetics Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 12, 2024

16 أكتوبر 2024 08:00:00 بحسب Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Announces October 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10 أكتوبر 2024 16:40:28 بحسب Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock

08 أكتوبر 2024 23:55:11 بحسب Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock

08 أكتوبر 2024 16:01:51 بحسب Nasdaq GlobeNewswire

Crinetics Submits New Drug Application for Paltusotine for the Treatment of Acromegaly

26 سبتمبر 2024 16:05:00 بحسب Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Announces September 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10 سبتمبر 2024 16:40:25 بحسب Nasdaq GlobeNewswire

Crinetics Pharmaceuticals to Participate in Two Upcoming Investor Conferences

29 أغسطس 2024 16:05:00 بحسب Nasdaq GlobeNewswire